Knight Therapeutics (KHTRF) Rating Reiterated by Raymond James  Fairfield Current

Knight Therapeutics (OTCMKTS:KHTRF)’s stock had its “buy” rating reissued by equities research analysts at Raymond James in a report issued on Wednesday …